key: cord-0964543-0krvsryi authors: Sandhu, Sunmeet; Chand, Satish; Bhatnagar, Anuj; Dabas, Rajeshwari; Bhat, Showkat; Kumar, Harish; Dixit, Prashant Kumar title: Possible association between IgA vasculitis and COVID‐19 date: 2020-11-25 journal: Dermatol Ther DOI: 10.1111/dth.14551 sha: 9789e1b004c821ba6f7e6c81ec007e682f10f583 doc_id: 964543 cord_uid: 0krvsryi nan ney biopsy was done which showed features of focal necrotizing, mesangial, and focal endocapillary proliferative IgA nephropathy with mesangial granular deposits of IgA ( Figure 3 ). Patient was promptly started on injection dexamethasone equivalent to 1 mg/kg of prednisolone for 10 days and shifted to oral prednisolone subsequently. Presence of poor prognostic findings on kidney biopsy with glomerular segmental tuft necrosis and cellular crescent formation prompted us to plan long-term immunosuppressants for at least three months duration. Hence, mycophenolate mofetil as steroid sparing agent was added to be continued for three months and oral prednisolone tapered off in one month. His cutaneous lesions, joint involvement and abdominal symptoms resolved, liver function tests, and urinalysis normalized over 2 weeks. The patient is under follow-up to look for long-term renal complications. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases Covid-19 related IgA vasculitis IgA vasculitis with nephritis (Henoch-Schönlein purpura) in a COVID-19 patient Association of the infectious triggers with childhood Henoch-Schonlein purpura in Anhui province Endothelial cell infection and endotheliitis in COVID-19 Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura) Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China